mesalamine has been researched along with Bechterew Syndrome in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sari, I | 1 |
Birlik, M | 1 |
Cavdar, C | 1 |
Sarioglu, S | 1 |
Akpinar, H | 1 |
Onen, F | 1 |
Akkoc, N | 1 |
Ritchlin, CT | 1 |
Daikh, BE | 1 |
1 review available for mesalamine and Bechterew Syndrome
Article | Year |
---|---|
Recent advances in the treatment of the seronegative spondyloarthropathies.
Topics: Ciprofloxacin; Female; Humans; Male; Mesalamine; Methotrexate; Prognosis; Prohibitins; Randomized Co | 2001 |
1 other study available for mesalamine and Bechterew Syndrome
Article | Year |
---|---|
Mesalazine-associated acute tubulointerstitial nephritis in a patient with spondylarthropathy.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Humans; Inflammatory Bowel Disea | 2005 |